546: When Speed to Market Matters Most | Richard Steinhart, CFO, Bioxcel Therapeutics
Summary: 546: When Speed to Market Matters Most | Richard Steinhart, CFO, Bioxcel Therapeutics
Summary: 546: When Speed to Market Matters Most | Richard Steinhart, CFO, Bioxcel Therapeutics